Loading…
Drugs, therapies, antibodies, gene and cell technology.
Part of Deep tech & other
By region: North America 125 · Europe 31 · China 11 · Other regions 8 · Korea 8 · Asia 6 · Japan 3
OMass Therapeutics, based at ARC Oxford (UK); site sections cover science, technology, pipeline and news.
RxActuator makes a pet-hospital-grade wearable infusion pump (Mini-Infuser) for pain management and drug delivery during pet recovery at home.
UNSW Sydney spinout developing a DNA sequencing platform based on a plasmonic nanoantenna that reads native DNA molecules without amplification.
Develops oligonucleotide (siRNA) therapies designed to reach and enter the specific cells that drive disease, starting with programs in FSHD muscular dystrophy and heart failure.
AI drug discovery platform
AI and Data for Cancer Therapeutics
AgTech company developing climate-resilient cereal seed varieties (salt-tolerant wheat, heat-resistant and nitrogen-efficient seeds) using its SeedAX biotech platform for trait…
NuSynth is an R&D-led process innovation platform that redesigns synthesis routes for complex chemistry (pharmaceutical and electronic chemicals) using fewer steps, safer…
Develops AI-driven delivery technology for siRNA therapeutics, using combinatorial chemistry screens and machine learning to carry siRNA into tissues beyond the liver; first…
AI-native CRO for clinical trial operations
Antibody-drug conjugate R&D
Virtual trials for drug R&D
Curing cancer. Starting with dogs.
Cancer radiation therapy drug, Kyoto University spin-off
Precision Chroma makes patented 3D-printed monolith adsorption (PMA) chromatography columns for purifying biological therapeutics from unclarified, solids-laden cell culture.
Predicts drug toxicity in human tissue before clinical trials
World model for human cells (drug discovery)
Edo microalgae protein.
Converts immune cells into therapeutics.
Building Clinical Superintelligence.
Unleash the potential of genomic medicine using AI
Automated biotech lab in the Amazon.
Non-opioid pain therapies.
Gene-reactivating RNA platform.
Third-generation DNA synthesis.
Bringing resuscitated drugs to market.
Medical nebulised drug delivery.
MOGLU, a needle-free wearable continuous glucose monitor using Raman spectroscopy; the site reports 11.34% MARD with 100% of readings in Parkes zones A/B in an IRB-approved study…
Survival predictions from radiology scans for cancer trials.
Neuroprosthesis for profound blindness.
AI cancer research.
Gene editing technology.
AI for drug discovery (Tsinghua AIR incubated).
RBC-based liquid biopsy.
Laboratory automation robots ('autonomous lab').
Developing early cancer detection technology based on RNA modification analysis.
Automated lab for agentic biology.
AI drug platform.
Cancer therapy.
Biotech.
Foundation models for AI drug discovery.
AI drug discovery / AI scientist agent for bio research
Domestic seaweed-based materials
Animal-free dairy proteins (casein) grown in oats
Immunotherapy for hard-to-treat solid tumours
Patient-derived AI drug discovery platform.
SwitchOn builds DeepInspect, an AI-powered computer-vision visual inspection system that automatically detects defective products on manufacturing production lines at…
AI-designed gene editors for agriculture and medicine.
Bio-new-drug developer with the ArkGen Multi-Body (AMB) multi-target antibody platform, a personalized neoantigen cancer vaccine, an LGR4 bone-disease therapeutic and TheraVac…
Cell therapy from chemically induced iPSCs (Parkinson's; NouvSight001 for retinitis pigmentosa).